2009•Journal of Chinese MicrocirculationRequires access

Effcet of Tongxinluo capsul on hs-CRP、TNF-a in patients with angina pectoris

Gao Chang-zhen

Open publisher page 0 citations

Abstract

Objective To investigate the protective effect and possible mechanisms of Tongxinluo capsul on angina pectoris. Methods Sixty-one patients with unstable angina pectoris(UA) were randomly divided into the control group(n=31) treated by conventional therapy and the treatment group(n=30) treated by Tongxinluo capsule on this basis. 4 weeks later,serum high sensitive C-reactive protein(hs-CRP) and tumor necrosis factor-a(TNF-a) were determined with ELISA before and after treatment. Results The levels of hs-CRP,TNF-a were significantly lower in both groups after treatment than those before treatment(P0.01),and the decrement in the treatment group was more significant than that in the control group(P0.01). Conclusion Tongxinluo casule could inhibit the development of angina pectoris through down-regulating the expresssion of serum TNF-α,decreasing serum hs-CRP concentration and inhibiting inflammatory reaction.

About this research paper

What this paper is about

Objective To investigate the protective effect and possible mechanisms of Tongxinluo capsul on angina pectoris. Methods Sixty-one patients with unstable angina pectoris(UA) were randomly divided into the control group(n=31) treated by conventional therapy and the treatment group(n=30) treated by Tongxinluo capsule on this basis. 4 weeks later,serum high sensitive C-reactive protein(hs-CRP) and tumor necrosis factor-a(TNF-a) were determined with ELISA before and after treatment. Results The levels of hs-CRP,TNF-a were significantly lower in both groups after treatment than those before treatment(P0.01),and the decrement in the treatment group was more significant than that in the control group(P0.01). Conclusion Tongxinluo casule could inhibit the development of angina pectoris through down-regulating the expresssion of serum TNF-α,decreasing serum hs-CRP concentration and inhibiting inflammatory reaction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the protective effect and possible mechanisms of Tongxinluo capsul on angina pectoris. Methods Sixty-one patients with unstable angina pectoris(UA) were randomly divided into the control group(n=31) treated by conventional therapy and the treatment group(n=30) treated by Tongxinluo capsule on this basis. 4 weeks later,serum high sensitive C-reactive protein(hs-CRP) and tumor necrosis factor-a(TNF-a) were determined with ELISA before and after treatment. Results The levels of hs-CRP,TNF-a were significantly lower in both groups after treatment than those before treatment(P0.01),and the decrement in the treatment group was more significant than that in the control group(P0.01). Conclusion Tongxinluo casule could inhibit the development of angina pectoris through down-regulating the expresssion of serum TNF-α,decreasing serum hs-CRP concentration and inhibiting inflammatory reaction.

Key concepts: Tumor necrosis factor alpha, Angina, Medicine, C-reactive protein, Stable angina, Internal medicine, Interleukin 6, Capsule

Related papers

Back to paper searchBrowse research topicsOriginal source
Effcet of Tongxinluo capsul on hs-CRP、TNF-a in patients with angina pectoris — Research Paper | ScholarLens